[go: up one dir, main page]

WO2008069972A3 - Systems for effecting cessation of tobacco use - Google Patents

Systems for effecting cessation of tobacco use Download PDF

Info

Publication number
WO2008069972A3
WO2008069972A3 PCT/US2007/024641 US2007024641W WO2008069972A3 WO 2008069972 A3 WO2008069972 A3 WO 2008069972A3 US 2007024641 W US2007024641 W US 2007024641W WO 2008069972 A3 WO2008069972 A3 WO 2008069972A3
Authority
WO
WIPO (PCT)
Prior art keywords
systems
tobacco use
effecting cessation
cessation
effecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/024641
Other languages
French (fr)
Other versions
WO2008069972A2 (en
Inventor
Igor Gonda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aradigm Corp
Original Assignee
Aradigm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/932,437 external-priority patent/US8256433B2/en
Priority claimed from US11/932,402 external-priority patent/US20080138294A1/en
Priority claimed from US11/931,867 external-priority patent/US20080138398A1/en
Priority claimed from US11/931,921 external-priority patent/US20080138399A1/en
Application filed by Aradigm Corp filed Critical Aradigm Corp
Priority to EP07867592A priority Critical patent/EP2086527A4/en
Publication of WO2008069972A2 publication Critical patent/WO2008069972A2/en
Publication of WO2008069972A3 publication Critical patent/WO2008069972A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates generally to a system, kit and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to pulmonary administration of a nicotine containing formulation to effect smoking cessation.
PCT/US2007/024641 2006-12-01 2007-11-30 Systems for effecting cessation of tobacco use Ceased WO2008069972A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07867592A EP2086527A4 (en) 2006-12-01 2007-11-30 Systems for effecting cessation of tobacco use

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US86823806P 2006-12-01 2006-12-01
US60/868,238 2006-12-01
US91104407P 2007-04-10 2007-04-10
US60/911,044 2007-04-10
US91318507P 2007-04-20 2007-04-20
US60/913,185 2007-04-20
US91651007P 2007-05-07 2007-05-07
US60/916,510 2007-05-07
US91719007P 2007-05-10 2007-05-10
US60/917,190 2007-05-10
US98207007P 2007-10-23 2007-10-23
US60/982,070 2007-10-23
US11/932,402 2007-10-31
US11/931,867 2007-10-31
US11/932,437 2007-10-31
US11/932,437 US8256433B2 (en) 1999-07-16 2007-10-31 Systems and methods for effecting cessation of tobacco use
US11/932,402 US20080138294A1 (en) 1999-07-16 2007-10-31 Systems and methods for effecting cessation of tobacco use
US11/931,921 2007-10-31
US11/931,867 US20080138398A1 (en) 1999-07-16 2007-10-31 Dual release nicotine formulations, and systems and methods for their use
US11/931,921 US20080138399A1 (en) 1999-07-16 2007-10-31 Dual release nicotine formulations, and systems and methods for their use

Publications (2)

Publication Number Publication Date
WO2008069972A2 WO2008069972A2 (en) 2008-06-12
WO2008069972A3 true WO2008069972A3 (en) 2008-10-30

Family

ID=39492806

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/024641 Ceased WO2008069972A2 (en) 2006-12-01 2007-11-30 Systems for effecting cessation of tobacco use
PCT/US2007/024636 Ceased WO2008069970A2 (en) 2006-12-01 2007-11-30 Nicotine formulations, kits and systems and methods for their use

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2007/024636 Ceased WO2008069970A2 (en) 2006-12-01 2007-11-30 Nicotine formulations, kits and systems and methods for their use

Country Status (2)

Country Link
EP (2) EP2086527A4 (en)
WO (2) WO2008069972A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5254616B2 (en) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP2012517402A (en) * 2009-02-11 2012-08-02 ヘグルンド、エー．エス． Composition for buccal absorption of nicotine for smoking cessation
WO2011023796A1 (en) * 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
TWI484958B (en) * 2011-05-19 2015-05-21 Heglund A S A composition for buccal absorption of nicotine for the purpose of smoking cessation
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE
RU2541312C2 (en) * 2011-08-31 2015-02-10 Александр Васильевич Иващенко Pharmaceutical composition, method for preparing and device for using it
US10556011B2 (en) * 2011-12-02 2020-02-11 Joshua D. Levine Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
US10034988B2 (en) 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
WO2015042412A1 (en) 2013-09-20 2015-03-26 E-Nicotine Technology. Inc. Devices and methods for modifying delivery devices
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
CN110300588A (en) * 2017-03-07 2019-10-01 菲利普莫里斯生产公司 Inhalable nicotine composite and production and preparation method thereof
JP7420797B2 (en) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド Drug delivery methods and systems
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
EP3880175A4 (en) 2018-11-16 2022-08-17 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
JP7551621B2 (en) 2018-12-28 2024-09-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Liquid nicotine formulations containing low molar mass metal salts

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099999A1 (en) * 2000-11-01 2007-05-03 Epstein Mel H Methods of treating depression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
DK0557129T3 (en) * 1992-02-20 1997-04-14 Wielligh Johannes Louw Kot Von Product to help smokers quit smoking
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
US6799576B2 (en) * 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
CA2378913C (en) * 1999-07-16 2010-02-23 Aradigm Corporation System for effecting smoke cessation
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US6759435B1 (en) * 2003-07-03 2004-07-06 A.P. Group Inc. Antidepressant drugs and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099999A1 (en) * 2000-11-01 2007-05-03 Epstein Mel H Methods of treating depression

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2086527A4 *

Also Published As

Publication number Publication date
WO2008069970A3 (en) 2008-10-16
EP2086317A4 (en) 2010-03-03
WO2008069972A2 (en) 2008-06-12
WO2008069970A2 (en) 2008-06-12
EP2086317A2 (en) 2009-08-12
EP2086527A4 (en) 2010-03-03
EP2086527A2 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
WO2008069972A3 (en) Systems for effecting cessation of tobacco use
WO2007087431A3 (en) Sublingual fentanyl spray
EP2100524A4 (en) Low fire spreading cigarette, wrapping paper for the cigarette, and method of producing wrapping paper
WO2009141321A3 (en) Tablettable chewing gums comprising nicotine and a buffering agent
WO2009017837A3 (en) Sublingual fentanyl spray
UA88172C2 (en) Method for forming a flavored filter for a smoking article (variants), a smoking article (variants) and a filter for a smoking article (variants)
WO2012005885A3 (en) Nutraceutical product containing anatabine and yerba maté
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
WO2007091267A3 (en) Pulmonary delivery of alpha-i proteinase inhibitor
WO2011117733A8 (en) Smoking article with flavor delivery system
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2009108383A3 (en) Substituted xanthine derivatives
UA93903C2 (en) Tetrahydroisoquinoline derivatives to enhance memory function
WO2008144720A3 (en) Inhibitors of igf-1r signaling for the treatment of respiratory disorders
AP2150A (en) Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication.
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
WO2009115160A3 (en) Chewing composition and the use thereof
UA106653C2 (en) IMMOBILIZATION AND CONTROLLED RELEASE OF THE FLAVOR INCLUDING IN THE SUPREMOLECULAR COMPLEX
EP4268621A4 (en) Tobacco composition, tobacco-containing segment, non-combustion heating-type flavor inhaler, and non-combustion heating-type flavor inhalation system
EP4268619A4 (en) Tobacco composition, tobacco-containing segment, non-combustion heating-type flavor inhaler, and non-combustion heating-type flavor inhalation system
WO2008012086A3 (en) Protein-binding methotrexate derivatives, and medicaments containing the same
WO2008155390A3 (en) Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases.
WO2008122728A3 (en) Method for the nematocidal treatment of plants using eugenol and lecithine(s) and/or derivatives thereof
WO2007100430A3 (en) Cytisine and acetylcholine analogs and methods of treating mood disorders
IL195096A (en) Use of an aqueous solution of extract of tobacco leaves for the manufacture of a medicament for the treatment of tobacco dependence and kits comprising same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780050167.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07867592

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007867592

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE